Oasmia Pharmaceutical AB Clinical Trials
Studies registered on ClinicalTrials.gov (U.S. National Library of Medicine) with the company as lead sponsor or collaborator, newest start first. Values are as registered.
- 2009-02: Study NCT00989131; Company role Lead sponsor; Phase Phase 3; Status Completed.
| Start date | Study | Company role | Phase | Status | Conditions | Enrollment | Completion date |
|---|---|---|---|---|---|---|---|
| 2009-02 | NCT00989131 Study of Paclitaxel in Patients With Ovarian Cancer | Lead sponsor | Phase 3 | Completed | Epithelial Ovarian Cancer; Primary Peritoneal Cancer; Fallopian Tube Cancer | 789 | 2013-10 |